Nektar Therapeutics
NKTR
#5687
Rank
$1.15 B
Marketcap
$56.90
Share price
-1.37%
Change (1 day)
271.90%
Change (1 year)

Nektar Therapeutics (NKTR) - Total assets

Total assets on the balance sheet as of September 2025 : $0.30 Billion USD

According to Nektar Therapeutics 's latest financial reports the company's total assets are $0.30 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Nektar Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$0.30 B-23.66%
2023-12-31$0.39 B-43.99%
2022-12-31$0.71 B-36.39%
2021-12-31$1.11 B-27.4%
2020-12-31$1.53 B-22.18%
2019-12-31$1.97 B-8.04%
2018-12-31$2.15 B322.54%
2017-12-31$0.50 B-10.55%
2016-12-31$0.56 B14.08%
2015-12-31$0.49 B12.91%
2014-12-31$0.44 B1.63%
2013-12-31$0.43 B-12.71%
2012-12-31$0.49 B-17.93%
2011-12-31$0.60 B16.37%
2010-12-31$0.52 B-9.43%
2009-12-31$0.57 B2.67%
2008-12-31$0.56 B-22.7%
2007-12-31$0.72 B-5.61%
2006-12-31$0.76 B-10.53%
2005-12-31$0.85 B15.25%
2004-12-31$0.74 B20.77%
2003-12-31$0.61 B1.67%
2002-12-31$0.60 B-9.08%
2001-12-31$0.66 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
$90.14 B 29,812.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$208.73 B 69,166.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$129.54 B 42,888.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
$0.20 B-33.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$114.45 B 37,881.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
$21.06 B 6,890.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
$2.32 B 673.03%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
$192.81 B 63,884.71%๐Ÿ‡บ๐Ÿ‡ธ USA